Acute Neutrophilic Dermatosis Induced by All-Trans-Retinoic Acid Treatment for Acute Promyelocytic Leukemia
- 1 January 1999
- journal article
- case report
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 34 (3-4) , 401-404
- https://doi.org/10.3109/10428199909050966
Abstract
All-trans-retinoic acid (ATRA) is considered the recommended induction treatment for acute promyelocytic leukemia (APL). Although the dermatological side effects associated with ATRA treatment are relatively common, acute neutrophilic dermatosis (Sweet's syndrome) has only been rarely reported. We describe such a case who responded to chemotherapy and not to low doses of corticosteroids.Keywords
This publication has 8 references indexed in Scilit:
- Acute neutrophilic dermatosis with myeloblastic infiltrate in a leukemia patient receiving all-trans-retnoic acid therapyPublished by Elsevier ,1994
- All-trans Retinoic Acid for Acute Promyelocytic Leukemia: Results of the New York StudyAnnals of Internal Medicine, 1994
- Sweet's syndrome associated with trans-retinoic acid treatment in acute promyelocytic leukemiaClinical and Experimental Dermatology, 1994
- Acute Promyelocytic LeukemiaNew England Journal of Medicine, 1993
- Sweet's syndrome associated with myelodysplasia: possible role of cytokines in the pathogenesis of the diseaseBritish Journal of Haematology, 1993
- The "Retinoic Acid Syndrome" in Acute Promyelocytic LeukemiaAnnals of Internal Medicine, 1992
- Sweet's syndrome and malignancyThe American Journal of Medicine, 1987
- Acute febrile neutrophilic dermatosis (Sweet-s syndrome) and myeloproliferative disordersCancer, 1983